Search clinical trials for: BMS-986345
Total 3182 results
-
Bristol-Myers SquibbCompletedHeart FailureFrance, Germany, Japan, Spain, United States, Argentina, Poland, Italy, Czechia, Greece, Netherlands, Canada, United Kingdom
-
Aegerion Pharmaceuticals, Inc.CompletedFamilial HypercholesterolemiaUnited States, Canada, Italy, South Africa
-
Bristol-Myers SquibbCompletedHepatitis CArgentina, Australia, Belgium, France, Germany, Italy, United States, Canada, Spain, Mexico, Austria, Poland, Netherlands, Korea, Republic of, Puerto Rico, New Zealand, Finland, Greece, Romania
-
Vanda PharmaceuticalsCompletedHealthy VolunteersUnited States
-
InspireMDCompletedMyocardial InfarctionPoland, South Africa
-
Allyx TherapeuticsYale University; National Institute on Aging (NIA)RecruitingAlzheimer's DiseaseUnited States
-
Columbia UniversityBristol-Myers Squibb; Ferring PharmaceuticalsActive, not recruiting
-
Aegerion Pharmaceuticals, Inc.FDA Office of Orphan Products DevelopmentCompletedHomozygous Familial HypercholesterolemiaUnited States, Canada, Italy, South Africa
-
InspireMDWithdrawnST Segment Elevated Myocardial InfarctionUnited Kingdom
-
Aegerion Pharmaceuticals, Inc.University of Pennsylvania; Doris Duke Charitable FoundationCompletedHomozygous Familial HypercholesterolemiaUnited States
-
Memorial Sloan Kettering Cancer CenterBristol-Myers SquibbCompletedGastric Cancer | Esophageal Cancer | Gastric Adenocarcinoma | Esophagogastric Cancer | Gastroesophageal Junction Adenocarcinoma | Esophagus Cancer | Gastroesophageal Junction Squamous Cell CarcinomaUnited States
-
Bristol-Myers SquibbWithdrawnHepatitis C VirusUnited States
-
Bristol-Myers SquibbOno Pharmaceutical Co. LtdCompletedBroad Solid TumorUnited States, Argentina, Australia, Canada, Chile, Japan, Romania, Singapore
-
CelgeneActive, not recruitingMultiple MyelomaUnited States, Canada, Italy, Czechia, Denmark, France, Germany, Greece, Spain
-
Bluedrop Medical LimitedRecruitingDiabetic FootUnited States
-
Bristol-Myers SquibbRecruitingSystemic Lupus ErythematosusUnited States, Taiwan, Japan, United Kingdom, Brazil, Colombia, Poland, Puerto Rico, China, France, Chile, Australia, Mexico, Germany, Argentina, India, Spain, Romania, Ireland
-
Janssen Research & Development, LLCBristol-Myers SquibbCompleted
-
R-PharmCompletedStomach NeoplasmsKorea, Republic of, Taiwan, Japan, Singapore, Hong Kong
-
BiogenCompletedProgressive Supranuclear PalsyUnited States
-
Bristol-Myers SquibbCompletedNon-Small Cell Lung CancerUnited States
-
Bristol-Myers SquibbTerminatedAlzheimer's DiseaseSweden, United States, Canada, Denmark, France, Finland
-
Bristol-Myers SquibbTerminatedNon Small Cell Lung CancerUnited States
-
Bristol-Myers SquibbCompletedAlzheimer's Disease
-
Bristol-Myers SquibbCompletedNon-Small Cell Lung CancerItaly, United States, Argentina, Belgium, Germany, Israel, Poland, Spain, Turkey, Australia, Chile, France
-
Bristol-Myers SquibbCompletedHealthy | Hepatitis CUnited States, Puerto Rico
-
Bristol-Myers SquibbJanssen, LPActive, not recruitingMultiple Myeloma | Hodgkin Lymphoma | Non-Hodgkin's LymphomaUnited States, Poland, Italy, Belgium, France, Greece
-
Ronald LevyBristol-Myers SquibbCompletedAdvanced Malignant Solid Neoplasm | Metastatic Malignant Solid Neoplasm | Extracranial Solid NeoplasmUnited States
-
Bristol-Myers SquibbCompletedHealthy Subjects and Atopic Dermatitis SubjectsUnited Kingdom
-
Janssen Research & Development, LLCBristol-Myers SquibbRecruitingAcute Coronary SyndromeUnited States, Taiwan, Korea, Republic of, Italy, South Africa, Israel, Belgium, Argentina, Malaysia, Romania, Serbia, China, Australia, Netherlands, United Kingdom, Denmark, Czechia, Hungary, Japan, France, Canada, Bulgaria, Spain, T... and more
-
Janssen Research & Development, LLCBristol Myers Squibb Company (BMS)RecruitingIschemic Stroke; Ischemic Attack, TransientItaly, United States, Hong Kong, Canada, Japan, China, Taiwan, South Africa, Korea, Republic of, Israel, United Kingdom, Argentina, Belgium, New Zealand, Australia, Germany, Czechia, Denmark, Mexico, Croatia, France, Brazil, Hungary, ... and more
-
Bristol-Myers SquibbActive, not recruitingMyelofibrosisItaly, Spain, United States, Australia, France, Germany, Greece, Hungary, Israel, Korea, Republic of, Poland, Romania
-
Bristol-Myers SquibbCompletedHealthy ParticipantsUnited Kingdom, Netherlands
-
Bristol-Myers SquibbTerminated
-
Bristol-Myers SquibbCompleted
-
National Cancer Institute (NCI)CompletedUnspecified Adult Solid Tumor, Protocol SpecificUnited States
-
M.D. Anderson Cancer CenterActive, not recruitingAdvanced Malignant Solid Neoplasm | Metastatic Malignant Solid Neoplasm | Metastatic Carcinoma in the Liver | Metastatic Carcinoma in the Lung | Metastatic Malignant Neoplasm in the Thoracic CavityUnited States
-
Janssen Research & Development, LLCCompleted
-
Bristol-Myers SquibbTerminated
-
Bristol-Myers SquibbCompletedRheumatoid ArthritisUnited States
-
R-PharmCompletedMetastatic Pancreatic CancerUnited States
-
R-PharmCompletedAdvanced/Metastatic Non-Small Cell Lung CancerGermany, Korea, Republic of, Russian Federation, Taiwan, Australia, Italy, France, United States, Argentina, Spain
-
Bristol-Myers SquibbWithdrawnMultiple Myeloma | Hodgkin Lymphoma | Non-Hodgkin's Lymphoma | Chronic Myelogenous Leukemia
-
Bristol-Myers SquibbMedarexCompleted
-
The University of Hong KongNot yet recruiting
-
Bristol-Myers SquibbCompletedModerate Liver Impairment | Severe Liver ImpairmentUnited States
-
Bristol-Myers SquibbCompleted
-
Bristol-Myers SquibbCompletedCongestive Heart Failure | Liver Dysfunction | Heart Decompensation | Cardiac Failure | Liver Insufficiency | Myocardial Failure | Hepatic FailureHungary, Poland
-
Bristol-Myers SquibbCompletedChronic Hepatitis CFrance, United States, Puerto Rico
-
Bristol-Myers SquibbActive, not recruitingA Study of BMS-986253 in Combination With Nivolumab or Nivolumab Plus Ipilimumab in Advanced CancersMelanoma | CancerUnited States, Poland, Italy, Belgium, France, Australia, Canada, Germany, Spain, Sweden, Switzerland, United Kingdom